Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.
Takano T, Tsubouchi K, Hamada N, Ichiki K, Torii R, Takata S, Kawakami S, Nakagaki N, Yoshida M, Kitasato Y, Tobino K, Harada E, Ishii H, Wataya H, Maeyama T, Fujita M, Yatera K, Okamoto M, Yabuuchi H, Kiyomi F, Tokunaga S, Nakanishi Y, Okamoto I. Takano T, et al. Among authors: kitasato y. BMC Pulm Med. 2024 Nov 6;24(1):556. doi: 10.1186/s12890-024-03347-5. BMC Pulm Med. 2024. PMID: 39506773 Free PMC article.
Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during "The Fifth Pandemic Wave" in Japan.
Inokuchi T, Homma T, Kitasato Y, Akiyama M, Chikasue A, Nishii Y, Ban S, Adachi T, Sonezaki A, Masuda H, Kamei H, Takenaka M, Tanaka M, Okamoto M, Hoshino T; K-COCOA (KURUME-COVID-19 THERAPEUTIC PROGRAM BY COLCHICINE AND LOW-DOSE ASPIRIN) STUDY COLLABORATORS. Inokuchi T, et al. Among authors: kitasato y. Kurume Med J. 2024 Jul 2;70(1.2):39-45. doi: 10.2739/kurumemedj.MS7012003. Epub 2024 Mar 19. Kurume Med J. 2024. PMID: 38508737 Free article.
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K, Hamada N, Tokunaga S, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Kawakami S, Yatera K, Kawasaki M, Fujita M, Yoshida M, Maeyama T, Harada T, Wataya H, Torii R, Komori M, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Nakanishi Y, Okamoto I. Tsubouchi K, et al. Among authors: kitasato y. BMJ Open Respir Res. 2023 Nov;10(1):e001864. doi: 10.1136/bmjresp-2023-001864. BMJ Open Respir Res. 2023. PMID: 37963676 Free PMC article.
Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study.
Ogata-Suetsugu S, Hamada N, Tsuda T, Takata S, Kitasato Y, Inoue N, Nagata N, Yatera K, Mukae H, Yoshii C, Hoshino T, Fujita M, Watanabe K, Tokunaga S, Nakanishi Y; Fukuoka tobacco-related lung disease (FOLD) registry study group, Fukuoka, Japan. Ogata-Suetsugu S, et al. Among authors: kitasato y. Respir Investig. 2020 Jan;58(1):74-80. doi: 10.1016/j.resinv.2019.10.002. Epub 2019 Nov 11. Respir Investig. 2020. PMID: 31727581
ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
Fukushima H, Yasumoto M, Ogasawara S, Akiba J, Kitasato Y, Nakayama M, Naito Y, Ishida Y, Okabe Y, Yasunaga M, Horiuchi H, Sakamoto E, Itadani H, Mizuarai S, Oie S, Yano H. Fukushima H, et al. Among authors: kitasato y. Mol Cancer. 2016 May 4;15(1):32. doi: 10.1186/s12943-016-0516-4. Mol Cancer. 2016. PMID: 27145964 Free PMC article.
39 results